<DOC>
	<DOCNO>NCT02310061</DOCNO>
	<brief_summary>Volume overload lead risk factor death cardiovascular event end stage renal disease patient maintain chronic dialysis , particularly myocardial ischemia heart failure represent substantial fraction population . Early identification volume overload may prevent cardiovascular sequel patient clinical sign volume expansion unsatisfactory reliably identify patient risk monitor time . On hand , however reliable , standard technique measure extracellular circulating ( blood ) volume convey information fundamental heart function parameter determine individual haemodynamic tolerance volume excess response ultrafiltration , i.e . leave ventricular ( LV ) filling pressure LV function . Extra-vascular lung water critically dependent parameter represent proxy , circulating volume LV filling pressure function , may therefore good criterion identify patient high risk volume-dependent adverse clinical outcome monitor effect therapy aim prevent outcome . A fast ( &lt; 5 min . ) , easy learn , simple non-expensive technique measure extra-vascular lung water use standard ultrasound ( US ) machine validate dialysis patient . Whether systematic measurement lung water technique may translate good clinical outcome End Stage Renal Disease ( ESRD ) patient never test . The aim randomize clinical trial test treatment policy guide extra-vascular lung water measurement ultrasound prevent death , decompensated heart failure myocardial infarction well progression Left Ventricular Hypertrophy ( LVH ) LV dysfunction hospitalization high risk dialysis patient myocardial ischemia ( history myocardial infarction without ST elevation unstable angina , acute coronary syndrome document ECG recording cardiac troponins stable angina pectoris document coronary artery disease prior coronary angiography ECG ) overt heart failure ( NYHA class III-IV ) .</brief_summary>
	<brief_title>Lung Water Ultrasound Guided Treatment Hemodialysis Patients ( The Lust Study ) .</brief_title>
	<detailed_description>Randomization procedure : After enrollment , patient randomize 2 group : treatment control . The randomization perform centre , 1:1 allocation ratio , communicate coordinate centre Reggio Calabria . An allocation concealment observe . Warning : base principle `` randomize , always randomize '' , patient drop study simply replace new one . New patient must randomize well . Validation core lab data : The core data collect LUST project/subprojects validate follow validation centre : - CORE LUST STUDY DATA Echocardiographic data US-lung data : Dr. Rosa Sicari Dr. Luna Gargani , CNR Institute Clinical Physiology Pisa , Italy ( rosas @ ifc.cnr.it ) . - ANCILLARY LUST PROJECTS Pulse Wave Velocity data ( PWV ) : Prof. Gerard London , Service d'Hémodialyse , Hôpital F.H . Manhès , Fleury-Mérogis , France ( glondon @ club-internet.fr ) . 24 Ambulatory Blood Pressure Monitoring ( ABPM ) data : Dr. Grzegorz Bilo , Istituto Auxologico Italiano Milan , Italy ( g.bilo @ auxologico.it ) . Preliminary training US-B line measurement pre-requisite Nephrologists Cardiologists participate centre . After training ( Skype meeting ) online certification release certify level expertise US-B line measurement LUST study nephrologists cardiologist . Each participant centre upload pertinent study ( echocardiography , 24h ABPM PWV data ) LUST website timely receive feedback validation centre , whenever need . US Lung Scan technique A standard ( 3.0-MHz ) echocardiography probe use purpose . Examinations perform supine position . To detect lung water , side chest scan anterior lateral part second fourth ( right side fifth ) intercostal space , parasternal , mid clavea , anterio-axillar mid-axillary line , previously describe ( Am J Cardiol 2004 ; 93:1265-70 ) . An US-B line hyperechoic , coherent US bundle narrow basis go pleura limit screen . These extended line ( also call comet ) arise pleural line differentiate short comet ' artifact may exist region . US-B line start pleural line either localize scattered whole lung present either isolate US-B line group ( distance &gt; 7 mm 2 extended comet ) . The sum US-B line produce score reflect extent LW accumulation . If detect US-B line , score 0 . The investigator warn fix US-B line , due lung water fibrosis inflammatory process . These comet register counted US-B line . The cause underlie artefact describe . In patient allocate active arm study , decision weight reduction take Nephrologists basis pre-dialysis US-scans . However , also post-dialysis US-B line measurement must perform registered . In active control arm well , US-scans perform local cardiologist coincidence echocardiographic study . It crucial purpose study cardiologist keep nephrologists involve LUST study blind respect number US-B line patient control group . Timing - In patient allocate control active arm , US-B line perform baseline 6 , 12 24 month local cardiologist , non-dialysis day either Thursday Friday , depend dialysis schedule . - In patient allocate treatment arm , application US-B scan perform follow : - In patient le 15 US-B line , ultrafiltration ( UF ) modify US-B line monitor performed nephrologist monthly interval ; - In patient 15 US-B line ( either baseline monthly US-B Lung scan ) UF perform schedule longer and/or additional dialysis ( see ) . In patient , monitor US pre-dialysis post-dialysis -B line repeat least week , goal achieve ( see next section ) . - Furthermore , patient active arm , pre- post-dialysis US-lung scan repeat discretion nephrologist , i.e . whenever he/she believe useful apply technique monitoring volume status patient , example patient &lt; 15 US-B line subsequently manifest rise body weight patient develop hypotension frank hypotensive episode dialysis . In brief , treatment group , monitor schedule week ( dialysis ) , even frequently nephrologist believe frequent monitoring may useful track desire UF goal . When number US-B line fall 15 , measurement repeat monthly interval . Weight reduction patient 15 US-B line In patient randomized treatment arm number US-B line &gt; 15 , decrease dry weight require reduce lung water , accord follow scheme derive pilot study coordinate centre Iasi Nephrology Unit : - 15-30 US-B line : decrease dry weight 300 g follow week ( 100 g per session ) - 31-40 US-B line : decrease dry weight 450 g follow week ( 150 g per session ) - &gt; 40 US-B line : decrease dry weight 600 g next week ( 200 g per session ) . Attempts low dry weight accord previous scheme continue US-B line goal ( &lt; 15 ) attain . If patient tolerate attempt decrease dry weight 2 week ( i.e . he/she develop hypotension , cramp symptom ) extra haemodialysis session consider . If goal ( &lt; 15 pre-dialysis US B-lines ) achieve 4-6 week , case patient tolerate UF , drug treatment ( carvedilol , ACEi , ARB ) intensification introduction consider . Once goal achieve , recommend confirm repeat measurement US-B line least , example follow dialysis . Warnings : - In patient active arm initial pre-dialysis US-B line &lt; 15 achieve goal thanks body fluid subtraction develop cramp and/or symptom extracellular volume depletion ( low dry weight ) decision increase dry weight accompany close US-B line monitoring ( i.e . every dialysis session patient stabilizes ) . - In patient &gt; 15 pre-dialysis US-B line tolerate dry weight decrease due hypotension hypotensive/cardioprotective drug treatment ( carvedilol/ACEi ) dose drug down-titrated stop , need . These drug patient always give dialysis ( go bed , night ) rather pre-dialysis . Clinical ( pre-dialysis ) evaluation volume status In group ( treatment control group ) , standard pre-dialysis clinical evaluation volume status do , recommend good clinical practice . This evaluation consider blood pressure change blood pressure time , pedal edema , presence/absence dyspnea , crackle lung auscultation ( see ) , body weight gain inter-dialysis body weight trajectory time . In active arm study data also formally register whenever US-B line measurement do . In control group , evaluation volume status need formally register coincidence echocardiographic study . The following scale use evaluation Crackles : 1 . No crackle 2 . I uncertain presence fine crackle 3 . Definite fine crackle lung base 4 . Moderate crackle 5 . Bilateral , diffuse crackle For clinical edema , follow scale use : 1 . No clinical edema 2 . Slight pitting ( 2 mm depth ) visible distortion 3 . Somewhat deep pit ( 4 mm ) readily detectable distortion 4 . Noticeably deep pit ( 6 mm ) dependent extremity full swollen 5 . Very deep pit ( 8 mm ) dependent extremity grossly distort Echocardiographic measurement In intervention control arm , cardiologist involve LUST study perform echocardiographic measurement baseline , 6 , 12 24 month , non-dialysis day Thursday Friday , depend dialysis schedule . These echocardiogram `` research echocardiogram '' . For reason , fundamental keep nephrologists blind result echocardiographic reading . Nevertheless , nephrologists allow consult cardiologist ( LUST cardiologist another one ) `` clinical echocardiogram '' clinical problem arise demand application echocardiographic study diagnostic reason monitor underlying cardiac problem . Detailed information standardization echocardiographic study prepare echocardiography validation laboratory ( Dr. Rosa Sicari Dr. Luna Gargani , IFC CNR , Pisa ) .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Age &gt; 18 year Dialysis vintage &gt; 3 month A history myocardial infarction without ST elevation unstable angina , acute coronary syndrome , document ECG recording cardiac troponins , stable angina pectoris document coronary artery disease prior coronary angiography ECG dyspnoea class IIIIV NYHA Written consent take part study Cancer advance non cardiac disease comorbidity ( e.g . endstage liver failure ) imposing poor shortterm prognosis Active infection relevant intercurrent disease Inadequate lung scan echocardiographic study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Dialysis</keyword>
	<keyword>ESRD</keyword>
	<keyword>lung congestion</keyword>
	<keyword>heart failure</keyword>
	<keyword>LW-US</keyword>
</DOC>